Luca Bolliger
Keine laufenden Positionen mehr
Karriereverlauf von Luca Bolliger
Ehemalige bekannte Positionen von Luca Bolliger
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Biopolo Ticino | Gründer | - | - |
BT&T Asset Management AG
 BT&T Asset Management AG Investment ManagersFinance BT&T Asset Management Ltd. (BT&T-AM) is an independent investment management firm which was established by Walter Meier in 1995. Based in Zurich, Switzerland, the firm manages assets for BT&T TimeLife AG, a closed-end mutual fund. | Corporate Officer/Principal | - | - |
| Basel Institute for Immunology | Corporate Officer/Principal | - | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - | - |
| NOVIMMUNE SA | Public Communications Contact | 01.11.2008 | - |
| Corporate Officer/Principal | 30.07.2009 | 30.07.2009 |
Ausbildung von Luca Bolliger
| Swiss Federal Institute of Technology | Undergraduate Degree |
Statistik
International
| Schweiz | 5 |
| Deutschland | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Public Communications Contact | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
BT&T Asset Management AG
BT&T Asset Management AG Investment ManagersFinance BT&T Asset Management Ltd. (BT&T-AM) is an independent investment management firm which was established by Walter Meier in 1995. Based in Zurich, Switzerland, the firm manages assets for BT&T TimeLife AG, a closed-end mutual fund. | Finance |
| Biopolo Ticino |
- Börse
- Insiders
- Luca Bolliger
- Erfahrung
